site stats

Prtk ownership

Webb5 maj 2024 · Selected key stats of Paratek Pharmaceuticals, Inc. (PRTK) including 10 year stock price and latest news. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. WebbPRTK (Paratek Pharmaceuticals) Beneish M-Score as of today (March 15, 2024) is -2.71. Beneish M-Score explanation, calculation, ... PRTK) Ownership Structure Tell Us Something Useful? By Yahoo Finance 2024-07-18 Paratek Pharmaceuticals Announces Inclusion of NUZYRA (omadacycline) in Chinas National Reimbursement Drug List (NRDL)

Institutions profited after Paratek Pharmaceuticals, Inc.

WebbPRTK - Paratek Pharmaceuticals, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart … Webb11 apr. 2024 · The current PRTK price target is $10.00. Learn why top analysts are making this price prediction for Paratek Pharmaceuticals at MarketBeat. Skip to main content. S&P 500 . DOW . QQQ 313.04. ... Institutional Ownership. Headlines. Options Chain. SEC Filings. Short Interest. Social Media. how to activate proline laptop https://chiriclima.com

What Is The Ownership Structure Like For Paratek …

Webb10 juli 2024 · The big shareholder groups in Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK) have power over the company. Institutions often own shares in more established companies, while it's not unusual to see... WebbCompany profile for Paratek Pharmaceuticals Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed PRTK description & address. Webb13 apr. 2024 · Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies … metcalf compounding brevard

Paratek Pharmaceuticals, Inc. Common Stock (PRTK)

Category:PRTK / Paratek Pharmaceuticals Inc - Institutional Ownership - Fintel

Tags:Prtk ownership

Prtk ownership

Paratek Pharmaceuticals, Inc. Common Stock (PRTK)

Webb9 sep. 2024 · A look at the shareholders of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) can tell us which group is most powerful. We can see that individual investors own the … Webb10 juli 2024 · The big shareholder groups in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) have power over the company. Institutions...

Prtk ownership

Did you know?

WebbRaymond James & Associates ownership in PRTK / Paratek Pharmaceuticals Inc - 13F, 13D, 13G Filings - Fintel.io. ... Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, ... WebbInstitutional and Fund Ownership - Buyers. Major holders that have opened new positions in PRTK / Paratek Pharmaceuticals Inc include Kathmere Capital Management, LLC, Natixis, Mackenzie Financial Corp, Prudential Financial Inc, Mirabella Financial Services Llp, Commonwealth Equity Services, Llc, CI Private Wealth, LLC, Arete Wealth Advisors ...

Webb31 mars 2024 · Of the 68 institutional investors that purchased Paratek Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the …

Webb14 apr. 2024 · Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Major Shareholder James D. Dondero Buys 106,000 Shares March 24, 2024 americanbankingnews.com Paratek … Webb29 rader · 13 mars 2024 · PDF Ownership: 11.0 & later: OWNERSHIP_STATE: New for …

Webb8 feb. 2024 · The company's largest shareholder is BlackRock, Inc., with ownership of 5.9%. Meanwhile, the second and third largest shareholders, hold 5.2% and 4.3%, of the shares outstanding, respectively. In...

Webb29 mars 2024 · FREE PRTK REPORT Initial Statement of Beneficial Ownership (3) March 29 2024 - 04:31PM Edgar (US Regulatory) Remarks: No securities are beneficially owned. … metcalf companyWebbParatek Pharmaceuticals Ownership Who are the major shareholders and have insiders been buying or selling? Recent Insider Transactions Insider Trading Volume Insider … metcalf committeeWebb176 rader · Paratek Pharmaceuticals Inc (NASDAQ:PRTK) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual … metcalf constructionWebb6 feb. 2024 · PRTK (Paratek Pharmaceuticals) WACC % as of today (February 06, 2024) is 8%. WACC % explanation, calculation, historical data and more how to activate prostateWebbParatek Pharmaceuticals (NASDAQ: PRTK) is owned by 39.70% institutional shareholders, 136.62% Paratek Pharmaceuticals insiders, and 0.00% retail investors. Nea Partners 10 L … metcalf company realtorsWebb13 apr. 2024 · PRTK Stock Overview Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life … metcalf construction renoWebb3 jan. 2024 · NasdaqGM:PRTK Ownership Breakdown January 2nd 2024 What Does The Institutional Ownership Tell Us About Paratek Pharmaceuticals? Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. metcalf compounding pharmacy